Behbahani Ali 4
4 · Korro Bio, Inc. · Filed Jun 11, 2026
Research Summary
AI-generated summary of this filing
Korro Bio (KRRO) Director Ali Behbahani Receives Award
What Happened
Ali Behbahani, a member of Korro Bio's board of directors, received a grant of 14,677 derivative shares on June 10, 2026. The award is reported at $0.00 per share (total reported value $0) and is recorded as a derivative award (transaction code A). This is an equity award to a non-employee director (routine compensation), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-06-10; Form 4 filed 2026-06-11 (timely filing).
- Transaction type/code: Grant/Award (A), derivative securities, $0.00 per share.
- Shares granted: 14,677 derivative shares. Reported total value: $0.
- Vesting: Per footnote F1, the award vests in full on the earlier of (i) one-year anniversary of the grant or (ii) the next annual meeting of stockholders, subject to continued service as a non-employee director.
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- No exercise, sale, or tax-withholding transaction reported in this filing.
Context
This appears to be a standard equity grant for a non-employee director as part of board compensation. Derivative awards at $0 typically represent restricted equity or similar awards subject to vesting; they do not involve an immediate cash outlay or sale. Such grants are common and do not by themselves indicate insider buying or selling sentiment.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-06-10+14,677→ 14,677 totalExercise: $10.59Exp: 2036-06-09→ Common Stock (14,677 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders, subject to continued service as a non-employee director through the applicable vesting date.